The First Hospital of China Medical University - Oncology Department Lung Cancer Group Trials

The First Hospital of China Medical University - Oncology Department Lung Cancer Group	Welcome, Profile Billing Logout

The First Hospital of China Medical University - Oncology Department Lung Cancer Group

Welcome, Profile Billing Logout

0 Trials

3 Trials

Active Trials Industry lead sponsorIndustry collaborator

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Jin, Bo

FGCL-4592-898, NCT05301517: A Study to Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Participants Receiving Chemotherapy Treatment for Non-Myeloid Malignancies

Completed

159

RoW

SEPO®, Recombinant human erythropoietin-α [rHuEPO-α], Roxadustat, FG-4592

FibroGen

Chemotherapy Induced Anemia

04/23

NCT05042375: A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer

Recruiting

450

RoW

camrelizumab + famitinib, pembrolizumab, camrelizumab

Jiangsu HengRui Medicine Co., Ltd.

Non-small Cell Lung Cancer

12/23

12/25

TQB2450-ALTN-III-01, NCT06469879: A Clinical Study of TQB2450 Combined With Anlotinib in Limited-Stage Small Cell Lung Cancer Patients

Not yet recruiting

358

RoW

TQB2450+Anlotinib, TQB2450 placebo + Anlotinib placebo

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Small Cell Lung Cancer Limited Stage

09/26

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites